![]() |
|
|
Vol. 26, Issue 5, 401-407, May 1998
College of Pharmacy, Seoul National University (M.G.L.), and
Department of Pharmaceutics and Pharmacodynamics, College of Pharmacy,
University of Illinois at Chicago (W.L.C.)
The following possible explanations for the significant increases
in the oral bioavailability and the diuretic and natriuretic effects of
orally administered furosemide observed when ascorbic acid was
coadministered to dogs were investigated: ascorbic acid might enhance
the gastrointestinal (GI) absorption of furosemide, might inhibit GI
wall metabolism of furosemide, might enhance the reabsorption of
furosemide from the renal tubules, and might increase the unionized
fraction of furosemide at the receptor sites. The significant increase
in the oral bioavailability with coadministration of ascorbic acid
seemed to result from reduced gastric first-pass metabolism of
furosemide and not enhanced GI absorption of furosemide. This might be
supported by rat studies; the percentages of the oral doses of
furosemide recovered from the GI tract at 8 hr after oral
administration were similar (p < 0.583)
without (39.5%) and with (44.7%) coadministration of ascorbic acid,
and the amounts of furosemide remaining per gram of stomach after
30-min incubations of 50 µg of furosemide with 9000g
supernatant fractions of stomach homogenates were increased significantly (48.5 vs. 42.4 µg) by the addition of 100 µg of ascorbic acid. The significant increases in the diuretic and
natriuretic effects of furosemide with ascorbic acid could be the
result of increases in the reabsorption of furosemide from renal
tubules and increases in the unionized fraction of furosemide at the
renal tubular receptor sites. This was supported by 1.5-4.2-fold
increases in urine output and approximately 20% decreases in the
time-averaged renal clearance of furosemide when the urine pH was
decreased by 1.5-2.5 units by oral administration of ammonium
chloride.